How much does Mirvaso cost?

Pricing for Mirvaso varies by insurance plan, dose, and pharmacy. Our database does not show a fixed cost because prices change faster than we can verify. For current pharmacy prices, check your insurance's formulary tier (in the prior-authorization section), use the GoodRx or Cost Plus Drugs deep links on this page, or ask your pharmacist to run a test claim. If a copay card is listed, it usually drops the out-of-pocket significantly for commercial insurance.

Does Mirvaso need prior authorization?

Mirvaso appears on 1 payer formulary in our database. PA requirements vary by payer — see the prior-authorization table on this page for specifics. In general, specialty and brand-name drugs are more likely to require PA than generic equivalents.

Is there a copay card or patient assistance program for Mirvaso?

We haven't verified an active copay card or PAP for Mirvaso in our current data. Check NeedyMeds or RxAssist for independent directories, or submit what you find via our "Report a broken link" form.

What is Mirvaso used to treat?

Mirvaso (generic: brimonidine tartrate) is indicated for Rosacea. Click any condition name on this page for more detail.

Does Mirvaso have a generic version?

The generic name for Mirvaso is brimonidine tartrate. Whether a generic is currently available depends on patent status — check the FDA Orange Book or ask your pharmacist. Generics are often substantially cheaper than brand-name drugs.

Mirvaso

Generic: brimonidine tartrate

Data may be stale·Apr 23, 2026

Manufacturer: Galderma
NDC: 0299-5980
RxCUI: 1437707
Route: TOPICAL
ICD-10 indication: L71.9

Affordability Check

How much will you actually pay for Mirvaso?

In 30 seconds, see every legitimate way to afford Mirvaso — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Mirvaso

What is this medication? Mirvaso is a prescription topical gel primarily used for the treatment of persistent facial redness associated with rosacea in adults. The active ingredient in this medication is brimonidine, which belongs to a class of drugs known as alpha-adrenergic agonists. It works by narrowing the blood vessels in the face, which helps to reduce the appearance of flushing and redness that often causes discomfort or self-consciousness for those living with the condition.

The medication is typically applied once daily in a small pea-sized amount to the forehead, chin, nose, and each cheek. It is important to note that Mirvaso is not a permanent cure for rosacea and does not treat the inflammatory bumps or pimples that can sometimes accompany the condition. Instead, it provides temporary relief from facial erythema, with effects generally starting within thirty minutes of application and lasting for up to twelve hours throughout the day.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

Cost Plus Drug Company

Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for brimonidine tartrate.

Browse Cost Plus medications →

GoodRx

Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.

Lookup Mirvaso →

NeedyMeds

Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.

Search for brimonidine tartrate →

RxAssist

PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.

Search PAPs →

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Mirvaso. Official source: DailyMed (NLM) · Label effective Mar 31, 2026

Indications and usage

Use relieves redness of the eye due to minor eye irritations

Dosage and administration

Directions adults and children 5 years of age and over: instill 1 drop in the affected eye(s) every 6-8 hours do not use more than 4 times daily remove contact lenses before use wait at least 10 minutes before re-inserting contact lenses after use if using other ophthalmic products while using this product, wait at least 5 minutes between each product to avoid contamination, do not touch tip of container to any surface replace cap after each use children under 5 years of age: consult a doctor

Warnings

Warnings For external use only Do not use if solution changes color or becomes cloudy Stop use and ask a doctor if you experience eye pain, changes in vision, continued redness or irritation of the eye condition worsens or persists for more than 3 days If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Rosacea

Medicare Part D coverage

How Mirvaso appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).

Covered by plans

35 of 5,499 plans

Most common tier

Tier 4

On 83% of covering formularies

Prior authorization required

50%

of covering formularies

Tier	Formularies on this tier	Share
Tier 1 (preferred generic)	1	17%
Tier 4 (non-preferred brand)	5	83%

Step therapy: 0% of formularies

Quantity limits: 0% of formularies

Coverage breadth: 6 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

Payer	PA	Step therapy	Copay tier
— Medicare Part D	—	—	—

Payer

Step therapy

Copay tier

—

Medicare Part D

—

Related drugs

How this page is sourced

Drug identity verified against openFDA NDC Directory.
Label text (when shown) originates from NLM DailyMed.
Copay and assistance URLs verified periodically; if you hit a broken link, tell us.